Results 291 to 300 of about 197,837 (340)
Some of the next articles are maybe not open access.

Vagus Nerve Stimulation

Journal of Psoriasis and Psoriatic Arthritis, 2018
Treatments for psoriasis and psoriatic arthritis have progressed at a rapid rate over the past 20 years, but treating patients with recalcitrant disease still remains a difficult task. Current therapies for these diseases involve topical agents, phototherapy, and systemic immunosuppression.
Eric J. Yang   +5 more
  +4 more sources

Transcutaneous vagus nerve stimulation - A brief introduction and overview.

Autonomic Neuroscience: Basic & Clinical, 2022
Invasive cervical vagus nerve stimulation (VNS) is approved for the treatment of epilepsies, depression, obesity, and for stroke-rehabilitation. The procedure requires surgery, has side-effects, is expensive and not readily available.
M. Hilz
semanticscholar   +1 more source

Vagus nerve stimulation therapy

Drugs of Today, 2004
Until recently, antiepileptic drugs and traditional epilepsy surgery were the two primary treatment options available to patients with epilepsy. Drug therapy, however, does not always control seizures and can be associated with negative side effects. Additionally, only a minority of patients are candidates for epilepsy surgery. Vagus nerve stimulation (
James W, Wheless, James, Baumgartner
openaire   +2 more sources

Vagus nerve stimulation in brain diseases: therapeutic applications and biological mechanisms.

Neuroscience and Biobehavioral Reviews, 2021
Brain diseases, including neurodegenerative, cerebrovascular and neuropsychiatric diseases, have posed a deleterious threat to human health and brought a great burden to society and the healthcare system. With the development of medical technology, vagus
Yue Wang   +6 more
semanticscholar   +1 more source

Vagus Nerve Stimulation

2015
Vagus nerve stimulation (VNS) therapy is used for halting those seizures of medically refractory epilepsy patients in which therapy by antiepileptic drugs (AEDs) has failed to provide any reasonable comfort. Another disease which can be treated by VNS is chronic or recurrent depression in adult patients that is unmanageable by antidepressant drugs.
  +5 more sources

Vagus nerve stimulation: An update on a novel treatment for treatment-resistant depression.

Journal of Neurological Sciences, 2022
In this review, we provide an overview of essential clinical trials examining the effect of vagal nerve stimulation (VNS) in treatment-resistant depression (TRD), the applicable neuroanatomy of the vagus nerve, and the proposed mechanism of action (MOA ...
Lojine Y. Kamel   +4 more
semanticscholar   +1 more source

Moving beyond belief: A narrative review of potential biomarkers for transcutaneous vagus nerve stimulation.

Psychophysiology, 2020
Transcutaneous vagus nerve stimulation (tVNS) is a non-invasive neurostimulation technique that is currently being tested as a potential treatment for a myriad of neurological and psychiatric disorders. However, the working mechanisms underlying tVNS are
A. Burger   +3 more
semanticscholar   +1 more source

Vagus Nerve Stimulation

2019
The use of neuromodulatory devices for the treatment of neurological disorders provides a non-invasive and non-pharmacologic therapeutic approach for patients. Recent years have seen a significant increase in the development and assessment of the efficacy of these devices to treat primary headache and facial pain disorders.
Colin Roberts, Carli Bullis
openaire   +2 more sources

A 12‐month pilot study outcomes of vagus nerve stimulation in Crohn's disease

Neurogastroenterology and Motility, 2020
The vagus nerve has anti‐inflammatory properties. We aimed to investigate vagus nerve stimulation (VNS) as a new therapeutic strategy targeting an intrinsic anti‐inflammatory pathway in a pilot study in Crohn's disease patients.
V. Sinniger   +8 more
semanticscholar   +1 more source

Transcutaneous auricular vagus nerve stimulation reduces pain and fatigue in patients with systemic lupus erythematosus: a randomised, double-blind, sham-controlled pilot trial

Annals of the Rheumatic Diseases, 2020
Objectives Musculoskeletal pain and fatigue are common features in systemic lupus erythematosus (SLE). The cholinergic anti-inflammatory pathway is a physiological mechanism diminishing inflammation, engaged by stimulating the vagus nerve.
C. Aranow   +10 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy